ES464297A1 - A procedure for the preparation of new beta-lactama derivatives. (Machine-translation by Google Translate, not legally binding) - Google Patents

A procedure for the preparation of new beta-lactama derivatives. (Machine-translation by Google Translate, not legally binding)

Info

Publication number
ES464297A1
ES464297A1 ES464297A ES464297A ES464297A1 ES 464297 A1 ES464297 A1 ES 464297A1 ES 464297 A ES464297 A ES 464297A ES 464297 A ES464297 A ES 464297A ES 464297 A1 ES464297 A1 ES 464297A1
Authority
ES
Spain
Prior art keywords
carbon atoms
substituent
alkyl
aralkyl
nitro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES464297A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of ES464297A1 publication Critical patent/ES464297A1/en
Expired legal-status Critical Current

Links

Landscapes

  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

A procedure for the preparation of new β-lactam derivatives of the formula **(See formula)** where R1, R2 and R3 are independently selected from the group consisting of hydrogen and the following substituted and unsubstituted groups: C1-C10-alkyl, C2-alkenyl-alkynyl, cycloalkyl, cycloalkylalkyl, cycloalkylalkyl and cycloalkenylalkyl where the preceding cycloalkyl or cycloalkenyl radicals contain from 3 to 6 carbon atoms and the alkyl or alkenyl radicals contain from 1 to 6 carbon atoms, aryl of 6 to 10 carbon atoms, aralkyl, aralkenyl and aralkynyl of 6 to 10 atoms ring carbon and 1 to 6 chain carbon atoms, heteroaryl, heteroaralkyl, heterocyclyl and heterocyclylalkyl where the heterocyclic structure is monocyclic or bicyclic and contains 4 to 10 atoms of which 1 or more is selected from oxygen, sulfur and nitrogen and where the alkyl radical of said heterocycles contains 1 to 3 carbon atoms and where the substituent or substituents thereof The radicals mentioned above are selected from the group consisting of amino, hydroxyl, alkoxy of 1 to 6 carbon atoms, mercapto, alkylthio of 1 to 6 carbon atoms, sulfamoyl, amidino, guanidino, nitro, chloro, bromo, fluoro, cyano and carboxyl; with the proviso that when one of the radicals R1 or R2 is hydrogen and the other is 1-hydroxyxy, then R3 is not hydrogen, R'is a pharmaceutically acceptable ester radical or an easily cleavable blocking group and R''is selected independently among the following substituted and unsubstituted groups: aryl of 6 to 10 carbon atoms, aralkyl of 7 to 16 carbon atoms and alkyl of 1 to 6 carbon atoms where the substituent or substituents on R'' are selected from nitro, chlorine, bromine, fluorine or alkoxy of 1 to 3 carbon atoms, the process of which comprises; a) reacting a compound of the following structure: **(See formula)** where X is halogen with a reactive mercaptan, R0SH, selected to provide the R0 substituent to obtain a compound of formula **(See formula)** where R0 is independently selected from the following substituted and unsubstituted groups: aryl of 6 to 10 carbon atoms, aralkyl of 7 to 16 carbon atoms and alkyl of 1 to 6 carbon atoms, where the substituent or substituents on R0 are selected between nitro, chlorine, bromine, fluorine or alkoxy of 1 to 3 carbon atoms and the rest of the symbols have the meanings indicated above; b) React the product from the previous step with a selected organometallic reagent so as to provide the R3 substituent. (Machine-translation by Google Translate, not legally binding)
ES464297A 1976-11-19 1977-11-18 A procedure for the preparation of new beta-lactama derivatives. (Machine-translation by Google Translate, not legally binding) Expired ES464297A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US74337076A 1976-11-19 1976-11-19
US74336376A 1976-11-19 1976-11-19
US84317177A 1977-10-19 1977-10-19

Publications (1)

Publication Number Publication Date
ES464297A1 true ES464297A1 (en) 1978-11-16

Family

ID=27419292

Family Applications (2)

Application Number Title Priority Date Filing Date
ES464297A Expired ES464297A1 (en) 1976-11-19 1977-11-18 A procedure for the preparation of new beta-lactama derivatives. (Machine-translation by Google Translate, not legally binding)
ES473991A Expired ES473991A1 (en) 1976-11-19 1978-10-05 A procedure for the preparation of new derivatives of acids 1-carba-2-penem-3-carboxilicos. (Machine-translation by Google Translate, not legally binding)

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES473991A Expired ES473991A1 (en) 1976-11-19 1978-10-05 A procedure for the preparation of new derivatives of acids 1-carba-2-penem-3-carboxilicos. (Machine-translation by Google Translate, not legally binding)

Country Status (4)

Country Link
DK (1) DK512077A (en)
ES (2) ES464297A1 (en)
NO (1) NO150438C (en)
PT (1) PT67287B (en)

Also Published As

Publication number Publication date
DK512077A (en) 1978-05-20
NO150438C (en) 1984-10-17
PT67287B (en) 1981-09-30
PT67287A (en) 1977-12-01
NO150438B (en) 1984-07-09
ES473991A1 (en) 1979-05-16
NO773939L (en) 1978-05-22

Similar Documents

Publication Publication Date Title
IE40014L (en) Heterocyclic-alkylamino-heterocyclic compounds
MY108967A (en) Triazolopyridazine compounds, their production and use
PT74720B (en) Process for preparing modified d.retro cyclic hexapeptide somatostatin analogs
GB1464583A (en) Preparation of quinazoline derivatives
AU5478796A (en) Rigidized monomethine cyanine dyes
SE7712630L (en) PROCEDURE FOR THE PREPARATION OF O-ALKYLATED HYDROXYLAMINES
KR910004569A (en) (Quinolin-2-yl-methoxy) phenylacetic acid derivatives with cyclic substituents
ES8507146A1 (en) Penem derivatives and precursors.
GB1364403A (en) 1 - aminosulphonyl - 2 - aminobenzimidazoles process for their preparation and their fungicidal use
ES446993A1 (en) Pharmaceutical formulations containing hydrocy bezophenonederivatives
ES464297A1 (en) A procedure for the preparation of new beta-lactama derivatives. (Machine-translation by Google Translate, not legally binding)
DE69322673T2 (en) Imidazopyridazines as antiasthmatics
AU4843096A (en) Arylpiperidine and arylpiperazine derivatives and medicament containing the same
GB1525892A (en) Process for preparing 1-polyhaloalkyl-3,4-dihydro-2-(1h)-quinazolinones
IL113543A0 (en) 3-substituted pyridine derivatives compositions containing them and their use
GB1380095A (en) Carboxamidobenzoic acids as hypolipemic agents
CA2093510A1 (en) Oxysulfonyl carbamates
GB1423644A (en) 6-phenyl-s-triazolobenzotriazepines
NZ189091A (en) Prostaglandin derivatives
KR950700266A (en) Novel acid anhydrides and preparation and use thereof
GB1463582A (en) Pyridine derivatives
KR870006063A (en) 1-H-pyrido- [3,2-b] [1,4] -thiazine and preparation method thereof
Greenley Q and e Values of Telogens
GB1054655A (en)
JPS643187A (en) Pyrazolo(1,5-a)-1,3,5-benzotriazepine based compound